Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RAAS Nutritionals develops healthcare nutrition and dietary supplement products with a focus on functional foods derived from natural sources such as grape, soy, edamame, and rice. The company has conducted clinical investigations into the efficacy of its supplements for improving symptoms and reducing viral load in COVID‑19 patients. However, these are positioned as dietary supplements rather than drugs. There is no evidence of approved pharmaceutical drugs or advanced-stage therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RAAS Nutritionals.